New review highlights horses’ role in West Nile surveillance

A new review in Pathogens makes the case that horses should play a more visible role in Europe’s West Nile virus surveillance strategy, especially as climate-linked shifts in mosquito activity and viral circulation complicate outbreak prediction. Published in March 2026, the paper synthesizes European evidence from 2010 through 2025 and frames equine surveillance as part of a practical One Health system that can complement human case reporting, bird monitoring, and mosquito testing. (mdpi.com)

That message lands in a region where West Nile virus is already monitored through a coordinated European framework. EFSA says Member States must notify primary animal outbreaks within 24 hours under EU rules, with equine and bird outbreaks reported through the Animal Disease Information System, while EFSA and ECDC jointly track infections in humans, equids, and birds. EFSA also launched a West Nile virus dashboard in 2024, and its 2025 early-season update reported five outbreaks in equids and birds in the EU as of July 2, with no human cases yet recorded at that point in the season. (efsa.europa.eu)

The review’s core argument is that equine data can strengthen situational awareness when combined with entomological and avian surveillance. The authors note that Europe’s West Nile epidemiology is shaped by interacting factors including temperature, rainfall, drought, wetlands, irrigation, bird migration, and the distribution of competent Culex mosquitoes. They cite Italy’s 2022 epidemic as an example of integrated surveillance working as intended: mosquito and bird detections came weeks before human or equine cases, showing how animal and vector signals can provide earlier warning than clinical human surveillance alone. (mdpi.com)

A second 2026 review in Viruses broadens that point beyond Europe. It describes a Latin American pattern in which West Nile virus is repeatedly documented in vectors and animal hosts, including horses, but confirmed human cases remain comparatively sparse. The authors argue that this gap likely reflects underdiagnosis and surveillance limitations rather than absence of risk. Together, the two reviews reinforce the same operational lesson: veterinary and animal-health data may reveal viral circulation that human case counts miss. (mdpi.com)

For equine practice, though, the surveillance value of horses comes with diagnostic limits. CDC guidance notes that equine cases can serve a sentinel function, but active use of horses as sentinels is “theoretically possible” yet “practically infeasible” in many settings. The companion Veterinary Sciences review, cited in the source package, helps explain why: horses typically have short, low-level viraemia, which reduces the usefulness of molecular assays and pushes diagnosis toward serology, where cross-reactivity with other flaviviruses can complicate interpretation. That means veterinary awareness, timing of sample collection, and access to confirmatory testing remain central to making equine surveillance useful. (cdc.gov)

Industry and regulatory context also supports the paper’s One Health framing. WOAH says horses are dead-end hosts and should not trigger trade restrictions, but it continues to treat West Nile fever as a listed disease requiring reporting by member countries. WOAH has also been updating international standards for equine encephalitides with an explicit One Health emphasis, reflecting the need to align animal health surveillance, public health risk management, and horse movement policies. (woah.org)

Why it matters: For veterinarians, the article is less about a new outbreak than a sharper definition of where equine medicine fits in arbovirus intelligence. Horses won’t amplify West Nile virus, but they can still provide clinically meaningful signals about local transmission, particularly in areas with incomplete mosquito trapping or fragmented wildlife surveillance. That has implications for neurologic workups, vaccination discussions, client communication, and reporting pathways. It also reinforces the value of veterinary participation in regional surveillance networks, because a single equine case may be epidemiologically more important than it first appears. (mdpi.com)

What to watch: The next test will be the 2026 European transmission season and whether public health and veterinary agencies further integrate equine case detection with mosquito, bird, and climate-based risk tools. If recent European and Latin American analyses are right, the biggest gains may come not from any single surveillance stream, but from connecting them earlier and acting on weak signals before human case counts rise. This is an inference based on the reviews’ emphasis on integrated surveillance and the existing EFSA-ECDC reporting framework. (mdpi.com)